Cautionary Letter Regarding Electrical Stimulation Devices

Sharla Helton MD, Gretch Elizabeth - Tox Safety
5 minutes ago
6 min read

Sharla Helton MD, Gretch Elizabeth - Tox Safety

June 8, 2026

This letter and accompanying review were prompted by the increasing number of inquiries we have recently received regarding the use of electrical stimulation devices in individuals recovering from botulism, experiencing suspected systemic botulinum toxin effects, or living with persistent neurological symptoms following botulinum toxin exposure. Within the patient community, some individuals have previously reported possible symptomatic improvement in pain or muscle discomfort with certain forms of electrical stimulation therapy. However, over time, we have also received a growing number of reports describing significant symptom worsening, neurological relapses, increased fatigue, muscle weakness, autonomic instability, and prolonged functional setbacks following their use.

Importantly, despite the expanding use of these devices in rehabilitation and pain management settings, there are currently no evidence-based clinical studies specifically evaluating the safety, physiological effects, or long-term neurological impact of electrical stimulation therapies in individuals with botulism or suspected systemic botulinum toxin injury. To our knowledge, this represents one of the first comprehensive attempts to examine this issue through the lens of existing neuromuscular junction science, peripheral nerve regeneration literature, autonomic physiology, and the collective clinical experiences emerging within this patient population.

In light of these increasingly concerning reports, combined with the absence of direct safety data in this uniquely vulnerable population, we felt it was important to conduct a review of the currently available scientific literature and present a precautionary discussion regarding the potential risks and theoretical concerns associated with these therapies until more formal investigation can be performed.

Understanding the Different Types of Electrical Stimulation

Not all electrical stimulation devices are the same, and understanding these distinctions is important.

TENS (Transcutaneous Electrical Nerve Stimulation): Primarily designed for pain control. Although conventional TENS is generally intended to stimulate sensory nerve fibers at submotor thresholds, unintended or mild motor activation can still occur depending on stimulation parameters, electrode placement, tissue characteristics, and patient sensitivity.
NMES / EMS (Neuromuscular or Electrical Muscle Stimulation): Designed to create visible muscle contraction by stimulating motor nerves. These devices directly activate the neuromuscular junction and muscle fibers.
Russian Stimulation / Functional Electrical Stimulation (FES): Higher-intensity forms of motor stimulation commonly used in rehabilitation and athletic training.
Microcurrent or Cosmetic Electrical Devices: Often marketed for recovery, beauty, circulation, or muscle toning. Despite lower current, these devices still alter nerve and cellular electrical activity.

Why This Matters in Botulism and Post-Botulinum Toxin Illness

Electrical stimulation is not biologically neutral. A pilot study by Picelli and colleagues demonstrated that electrical stimulation applied immediately after botulinum toxin injection appeared to enhance the clinical effect of the toxin. The proposed mechanism was increased uptake of botulinum toxin into motor nerve terminals during periods of heightened neuromuscular activity.

This finding has significant implications for individuals already suffering from botulinum toxin-related injury or systemic symptoms. If electrical stimulation enhances toxin uptake into neurons, an important safety concern emerges: could stimulation increase internalization of toxin that remains present in tissue, extracellular fluid, lymphatics, or circulation?

At present, no study can reliably answer how long biologically active toxin may remain available in symptomatic individuals after injection, nor whether electrical stimulation during this period could worsen uptake into vulnerable nerves. This uncertainty is especially concerning because botulinum toxin is extraordinarily potent, and systemic spread following local injection has been documented in both clinical reports and mechanistic literature. Experimental studies have also demonstrated prolonged persistence of botulinum toxin activity within neurons, including long-lasting SNAP-25 cleavage and evidence of retrograde transport into central nervous system structures. Some experimental models have demonstrated persistent toxin-related biologic effects months after exposure, with evidence of cleaved SNAP-25 and ongoing intracellular toxin activity long after the initial peripheral exposure. While the clinical significance of these findings in humans remains incompletely understood, they raise important unanswered safety questions regarding whether electrical stimulation could influence toxin internalization, intracellular trafficking, persistence, or neuronal recovery in susceptible individuals recovering from botulism or systemic botulinum toxin injury. Experimental data further demonstrate that botulinum toxin is capable of retrograde axonal transport after internalization into neurons. In other words, the toxin may not remain confined to the injection site. Once inside the neuron, toxin can travel proximally along axons and may affect distant neuronal structures. No studies have determined whether electrical stimulation alters this transport process, accelerates axonal trafficking, or increases the likelihood of central nervous system exposure.

These unanswered questions are particularly important in patients already experiencing dysautonomia-like symptoms, generalized weakness, cranial neuropathies, fatigue, sensory disturbances, or progressive neurological decline after botulinum toxin exposure.

Reduced Safety Factor at the Neuromuscular Junction

In botulism, the neuromuscular junction operates with a markedly reduced safety factor because botulinum toxin blocks acetylcholine release by cleaving SNARE proteins necessary for synaptic vesicle fusion. This means the neuromuscular junction is already functioning under compromised conditions.

Motor-level electrical stimulation repeatedly activates already-stressed motor units and neuromuscular junctions. Theoretical concerns exist that repetitive electrically induced contractions could further stress impaired transmission or worsen fatigue in junctions already depleted of releasable acetylcholine.

This concern may be particularly important in vulnerable individuals with borderline respiratory or bulbar muscle function. In botulism and systemic botulinum toxin illness, respiratory failure can occur when weakened respiratory muscles are unable to sustain adequate ventilation. Because neuromuscular transmission in these patients already operates near physiologic failure thresholds, excessive electrically induced muscle activation could theoretically worsen fatigability, increase transmission failure, or temporarily exhaust already compromised motor units. In susceptible individuals, even modest additional impairment of diaphragmatic, intercostal, accessory respiratory, or bulbar musculature could potentially contribute to shortness of breath, reduced ventilatory reserve, impaired airway protection, dysphagia, pneumonia, aspiration pneumonia, or progression toward respiratory decompensation.

While these risks have not been adequately studied in controlled human trials, the underlying physiology of impaired neuromuscular transmission provides a reasonable basis for caution, particularly in symptomatic individuals with generalized weakness, autonomic symptoms, exertional intolerance, or fluctuating respiratory complaints.

Electrical Stimulation and Reinnervation Concerns

An additional concern arises from experimental evidence suggesting that electrical stimulation may interfere with recovery itself.

In the study “Electrical Stimulation Delays Reinnervation in Denervated Rat Muscle” by Pinheiro-Dardis et al., electrical stimulation applied to denervated muscle delayed reinnervation and altered expression of genes critical to neuromuscular junction repair and synapse formation.

This finding is highly relevant to botulism recovery. Recovery from botulism depends heavily on nerve terminal sprouting, reinnervation, and formation of new neuromuscular junctions. Importantly, prior literature demonstrates that reinnervation after botulinum toxin injury is often incomplete, with persistent abnormalities at the neuromuscular junction documented long after apparent clinical recovery.

If electrical stimulation interferes with reinnervation or modifies neuromuscular junction remodeling during recovery, then aggressive stimulation therapies could theoretically impair healing or prolong neurological dysfunction.

A Precautionary Principle is Warranted

At present, there are no adequate human safety studies evaluating electrical stimulation devices in individuals with systemic botulinum toxin illness, prolonged post-Botox neurological syndromes, or recovering botulism patients. The absence of direct evidence of harm should not be interpreted as evidence of safety.

When existing literature demonstrates that electrical stimulation can enhance botulinum toxin effect, increase toxin uptake into neurons, alter neuromuscular junction physiology, and potentially delay reinnervation in experimental models, a strong physiological basis exists for exercising caution.

In addition to these mechanistic and experimental concerns, anecdotal observations within our patient support community raise further reason for caution. Multiple individuals within the group have reported significant worsening or relapse of neurological symptoms following use of various electrical stimulation devices, including TENS, NMES, EMS, microcurrent, and other stimulation-based therapies. Reported reactions have included increased weakness, muscle fatigability, autonomic symptoms, respiratory complaints, sensory disturbances, and prolonged symptom exacerbation shortly after device use. While these observations are anecdotal and do not establish causation, the consistency of reports across multiple affected individuals warrants careful consideration, particularly in the absence of formal safety studies.

Importantly, the use of any electrical stimulation device should always occur only after individualized discussion between the patient and their treating physician, ideally under the guidance of clinicians familiar with neuromuscular junction disorders and botulinum toxin physiology. However, based on both the existing scientific literature and the collective experiences reported within the patient community, we believe a precautionary approach is warranted until these therapies are properly studied in this vulnerable population.

Until more definitive safety data exist, individuals recovering from botulism or experiencing systemic post-botulinum toxin symptoms should exercise extreme caution regarding the use of TENS, NMES, EMS, FES, microcurrent devices, and other forms of electrical stimulation therapy. We will continue to update this information as additional scientific literature, mechanistic research, and clinical evidence become available regarding the safety of electrical stimulation in this population.

Selected References

Picelli A, et al. Immediate versus delayed electrical stimulation boosts botulinum toxin effect: a pilot study.
Pinheiro-Dardis CM, Erbereli BT, Gigo-Benato D, Castro PATS, Russo TL. Electrical stimulation delays reinnervation in denervated rat muscle.
Restani L, et al. Botulinum neurotoxin A undergoes retrograde axonal transport after hindlimb injection.
Pirazzini M, Rossetto O, Eleopra R, Montecucco C. Botulinum neurotoxins: biology, pharmacology, and toxicology.
Simpson LL. The origin, structure, and pharmacological activity of botulinum toxin.
de Paiva A, et al. Functional repair of motor endplates after botulinum toxin type A poisoning.